nab-Paclitaxel (Abraxane®): an albumin-bound cytotoxic exploiting natural delivery mechanisms into tumors

被引：0
作者：
J Iglesias
机构：
[1] Abraxis Bioscience,
来源：
Breast Cancer Research | / 11卷
关键词：
Paclitaxel; Docetaxel; Metastatic Breast Cancer; Taxanes; Polysorbate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 24 条
  • [21] A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: A Gynecologic Oncology Group Study
    Coleman, Robert L.
    Brady, William E.
    McMeekin, D. Scott
    Rose, Peter G.
    Soper, John T.
    Lentz, Samuel S.
    Hoffman, James S.
    Shahin, Mark S.
    GYNECOLOGIC ONCOLOGY, 2011, 122 (01) : 111 - 115
  • [22] Efficacy and safety of nanoparticle albumin-bound paclitaxel monotherapy as second-line therapy of cytotoxic anticancer drugs in patients with advanced non-small cell lung cancer
    Anzai, Masaki
    Morikawa, Miwa
    Okuno, Takehiro
    Umeda, Yukihiro
    Demura, Yoshiki
    Sonoda, Tomoaki
    Yamaguchi, Makiko
    Kanno, Kiyoshi
    Shiozaki, Kohei
    Ameshima, Shingo
    Akai, Masaya
    Ishizuka, Tamotsu
    MEDICINE, 2017, 96 (51)
  • [23] Adverse Event Profile for Nanoparticle Albumin-Bound Paclitaxel Compared With Solvent-Based Taxanes in Solid-Organ Tumors: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
    He, Fei
    Liu, Jiaxuan
    Shen, Xin
    Wang, Zijing
    Li, Qiao
    Li, Guohui
    ANNALS OF PHARMACOTHERAPY, 2022, 56 (08) : 898 - 909
  • [24] Efficacy of Nanoparticle Albumin-Bound Paclitaxel (nab-PTX) Monotherapy Can Be Improved after Treatment with Immune Checkpoint Inhibitor in Patients with Non-Small Cell Lung Cancer: Long-Term Follow-Up and Updated Analysis of Two Previous Prospective Clinical Studies
    Nakashima, Koki
    Umeda, Yukihiro
    Demura, Yoshiki
    Sonoda, Tomoaki
    Tada, Toshihiko
    Yamaguchi, Makiko
    Anzai, Masaki
    Kadowaki, Maiko
    Oi, Masahiro
    Honjo, Chisato
    Mitsui, Miho
    Waseda, Yuko
    Ishizuka, Tamotsu
    ONCOLOGY, 2024, 102 (07) : 593 - 603
123